Palliative Benefits of Treatment of Advanced Urothelial Cancer with A Progesterone Receptor Antagonist

Jerome H Check, Diane L Check Bs and Brooke A Neumann Do
Additional contact information
Jerome H Check: Cooper Medical School of Rowan University Camden, USA
Diane L Check Bs: Cooper Institute for Reproductive Hormonal Disorders, USA
Brooke A Neumann Do: Inspira Health Network Vineland, USA

Biomedical Journal of Scientific & Technical Research, 2024, vol. 57, issue 2, 49092-49095

Abstract: Treatment with daily oral mifepristone, a progesterone receptor (PR) antagonist which blocks immunomodulatory proteins.

Keywords: Journals on Medical Drug and Therapeutics; Journals on Emergency Medicine; Physical Medicine and Rehabilitation; Journals on Infectious Diseases Addiction Science and Clinical Pathology; Open Access Clinical and Medical Journal; Journals on Biomedical Science; List of Open Access Medical Journal; Journals on Biomedical Engineering; Open Access Medical Journal; Biomedical Science Articles; Journal of Scientific and Technical Research (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.008983.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.008983.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:57:y:2024:i:2:p:49092-49095

DOI: 10.26717/BJSTR.2024.57.008983

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().